After synthetic organic chemistry training at Université de Montréal and a post-doc at MIT, Christophe benefited from the large number of opportunities offered to innovative medicinal chemists at Merck Frosst. His entrepreneurial spirit let him to contribute significantly to the initial tools necessary to start two medicinal chemistry programs.

• 

  Chief Executive Officer (CEO) in Giiant Pharma

  Small molecule. big impact.